Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001918979-22-000001
Filing Date
2022-03-28
Accepted
2022-03-28 10:03:54
Documents
1
Effectiveness Date
2022-03-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6565
  Complete submission text file 0001918979-22-000001.txt   7616
Mailing Address 275 SECOND AVE STE. 200 WALTHAM MA 02451
Business Address 275 SECOND AVE STE. 200 WALTHAM MA 02451 617-203-7118
Aldebaran Therapeutics, Inc. (Filer) CIK: 0001918979 (see all company filings)

EIN.: 874756963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-439130 | Film No.: 22773530